Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.5510
-0.0333 (-5.70%)
At close: Jul 16, 2026
RVPH Stock Forecast
OTC-RVPH's stock price has decreased by -92.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, RVPH stock has a consensus rating of "Strong Buy" and an average price target of $17.5. The average 1-year stock price forecast is 3,076.04% higher than the current stock price, while the lowest is $5.00 (+807.44%) and the highest is $30 (+5,344.65%).
Price Target: $17.5 (+3,076.04%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on May 21, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for RVPH is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 4 | 4 | 2 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 5 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $30 | Buy | Reiterates | $30 | +5,344.65% | May 21, 2026 |
| Maxim Group | Maxim Group | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 8, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $1.5 → $1 | Buy | Reiterates | $1.5 → $1 | +81.49% | Apr 1, 2026 |
| D. Boral Capital | D. Boral Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.60
from -5.48
EPS Next Year
-1.90
from -1.60
EPS and Forward PE are based on non-GAAP adjusted numbers.